Published date: 26 April 2023
Withdrawn future opportunity
Contract summary
Industry
Pharmaceutical products - 33600000
Location of contract
United Kingdom, Isle of Man, Channel Islands
Value of contract
£215,000,000
Procurement reference
CM/PHS/22/5650/W
Published date
26 April 2023
Approach to market date
1 February 2024
Contract start date
1 July 2024
Contract end date
30 June 2026
Procedure type
Open procedure (above threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
Haemophilia-A
More information
Previous notice about this procurement
NHS National Framework Agreement for the supply of products for the treatment of Haemophilia A
- Future opportunity
- Published 17 March 2022, last edited 26 April 2023
Spend profile
Financial year | Budget |
---|---|
2024/2025 | £80,625,000 |
2025/2026 | £107,500,000 |
2026/2027 | £26,875,000 |
About the buyer
Contact name
Karen Bell
Address
Commercial Medicines Unit - NHS England
2nd Floor, Rutland House
Runcorn
WA7 2ES
England
Share this notice
Approach to market date: 1 February 2024